INTERNATIONAL PATENT: BIOMEA FUSION, INC. FILES APPLICATION FOR "COMBINATION OF A MENIN INHIBITOR WITH A PYRAZOLOPIPERIDINE GLP-1 RECEPTOR AGONIST FOR TREATING DIABETES AND OBESITY"

GENEVA, March 19 -- BIOMEA FUSION, INC. (726 Main StreetRedwood City, CA 94063) filed a patent application (PCT/US2025/045178) for "COMBINATION OF A MENIN INHIBITOR WITH A PYRAZOLOPIPERIDINE GLP-1 RECEPTOR AGONIST FOR TREATING DIABETES AND OBESITY" on Sep 05, 2025. With publication no. WO/2026/055512, the details related to the patent application was published on Mar 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BALAKRISHNAN, Mini (C/o Biomea Fusion, Inc.726 Main StreetRedwood City, CA 94063), BUTLER, Thomas (C/o Biomea Fusion, Inc.726 Main StreetRedwood City, CA 94063), HO, Kung-Hsien...